• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges in lung cancer therapy during the COVID-19 pandemic.

作者信息

Calabrò Luana, Peters Solange, Soria Jean-Charles, Di Giacomo Anna Maria, Barlesi Fabrice, Covre Alessia, Altomonte Maresa, Vegni Virginia, Gridelli Cesare, Reck Martin, Rizvi Naiyer, Maio Michele

机构信息

Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.

Centre Hospitalier Universitaire Vaudois, Oncology Department, Lausanne University, Lausanne, Switzerland.

出版信息

Lancet Respir Med. 2020 Jun;8(6):542-544. doi: 10.1016/S2213-2600(20)30170-3. Epub 2020 Apr 9.

DOI:10.1016/S2213-2600(20)30170-3
PMID:32278368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7146673/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f18/7146673/0860a53df128/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f18/7146673/cfe494e83e66/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f18/7146673/0860a53df128/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f18/7146673/cfe494e83e66/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f18/7146673/0860a53df128/fx1_lrg.jpg

相似文献

1
Challenges in lung cancer therapy during the COVID-19 pandemic.2019冠状病毒病大流行期间肺癌治疗面临的挑战。
Lancet Respir Med. 2020 Jun;8(6):542-544. doi: 10.1016/S2213-2600(20)30170-3. Epub 2020 Apr 9.
2
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.在新冠疫情期间，类似新冠病毒感染的检查点抑制剂肺炎。
Lung Cancer. 2020 Aug;146:376-377. doi: 10.1016/j.lungcan.2020.06.013. Epub 2020 Jun 17.
3
Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂、血管紧张素II受体阻滞剂与心血管疾病
Med J Aust. 2020 Jun;212(11):502-503.e1. doi: 10.5694/mja2.50622. Epub 2020 May 21.
4
A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.一名患有呼吸困难的肺癌患者：COVID-19大流行期间的诊断难题
Cancer Cell. 2020 Nov 9;38(5):611-612. doi: 10.1016/j.ccell.2020.10.005. Epub 2020 Oct 9.
5
The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.一名感染新型冠状病毒的肺肉瘤样癌患者的治疗及预后
Lung Cancer. 2020 Aug;146:373-375. doi: 10.1016/j.lungcan.2020.06.006. Epub 2020 Jun 12.
6
SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context.肺癌患者的新型冠状病毒2型感染：当前临床背景
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):684. doi: 10.1016/j.arbres.2020.03.018. Epub 2020 Mar 31.
7
Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.在 COVID-19 大流行期间的节拍口服长春瑞滨和肺癌治疗：单中心经验。
Lung Cancer. 2020 Jul;145:83-84. doi: 10.1016/j.lungcan.2020.05.001. Epub 2020 May 6.
8
Alert to Potential Contagiousness: A Case of Lung Cancer With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.警惕潜在传染性：一例合并无症状严重急性呼吸综合征冠状病毒2感染的肺癌病例
J Thorac Oncol. 2020 Jun;15(6):e82-e83. doi: 10.1016/j.jtho.2020.04.005. Epub 2020 Apr 17.
9
The diabetic lung: An easy target for SARS-CoV-2?糖尿病患者的肺部：是否是新冠病毒的易侵袭目标？
Diabetes Metab Res Rev. 2020 Nov;36(8):e3346. doi: 10.1002/dmrr.3346. Epub 2020 Jun 18.
10
Impact of COVID-19 pandemic on subarachnoid hemorrhage.新型冠状病毒肺炎大流行对蛛网膜下腔出血的影响。
J Neurosurg Sci. 2020 Aug;64(4):409-410. doi: 10.23736/S0390-5616.20.04963-2. Epub 2020 Apr 29.

引用本文的文献

1
Effect of aberrant fructose metabolism following SARS-CoV-2 infection on colorectal cancer patients' poor prognosis.新冠病毒感染后异常果糖代谢对结直肠癌患者预后不良的影响。
PLoS Comput Biol. 2024 Sep 27;20(9):e1012412. doi: 10.1371/journal.pcbi.1012412. eCollection 2024 Sep.
2
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis.一种改善免疫检查点抑制剂相关性肺炎管理的多学科方法。
Onco Targets Ther. 2024 Aug 22;17:673-681. doi: 10.2147/OTT.S470892. eCollection 2024.
3
Association of immune checkpoint inhibitors with SARS-CoV-2 infection rate and prognosis in patients with solid tumors: a systematic review and meta-analysis.

本文引用的文献

1
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
2
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.在2019冠状病毒病大流行期间管理癌症护理：为实现共同目标而灵活应变与协作。
J Natl Compr Canc Netw. 2020 Mar 20:1-4. doi: 10.6004/jnccn.2020.7560.
3
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations.
免疫检查点抑制剂与实体瘤患者 SARS-CoV-2 感染率和预后的关系：系统评价和荟萃分析。
Front Immunol. 2024 Jun 3;15:1259112. doi: 10.3389/fimmu.2024.1259112. eCollection 2024.
4
Lung Cancer Treatment Trends During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Claims and Order Data Analysis (2019-2021).2019年冠状病毒病（COVID-19）大流行期间的肺癌治疗趋势：索赔与订单数据分析（2019 - 2021年）
JTO Clin Res Rep. 2023 Aug 17;4(10):100560. doi: 10.1016/j.jtocrr.2023.100560. eCollection 2023 Oct.
5
Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome.基于药理学和转录组整合分析鉴定木犀草素作为治疗 COVID-19 相关肺腺癌的潜在药物。
Curr Med Chem. 2024;31(33):5432-5447. doi: 10.2174/0929867331666230908090326.
6
Safeguarding COVID-19 and cancer management: drug design and therapeutic approach.保障新冠疫情期间的癌症管理：药物设计与治疗方法
Open Res Eur. 2021 Jul 5;1:77. doi: 10.12688/openreseurope.13841.1. eCollection 2021.
7
Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.新冠疫情防控对肺癌、乳腺癌和结直肠癌病理诊断的影响。荷兰、新西兰和北爱尔兰的比较。
BMC Cancer. 2023 Jul 26;23(1):700. doi: 10.1186/s12885-023-11216-3.
8
Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy.接受免疫疗法治疗的新冠病毒肺炎患者的临床结果
Cancers (Basel). 2022 Dec 1;14(23):5954. doi: 10.3390/cancers14235954.
9
Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knows.COVID-19大流行期间肺癌患者的管理：注意事项与未知情况
Explor Target Antitumor Ther. 2022;3(3):321-336. doi: 10.37349/etat.2022.00085. Epub 2022 Jun 10.
10
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines.mRNA 疫苗加强针接种后，处于治疗活跃期的癌症患者中的 SARS-CoV-2 感染。
Eur J Cancer. 2022 Aug;171:143-149. doi: 10.1016/j.ejca.2022.05.018. Epub 2022 May 25.
免疫检查点抑制剂在胸部恶性肿瘤中的应用：IASLC 专家小组对现有证据的综述及推荐意见
J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
4
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.中国武汉 81 例新冠肺炎患者的放射学特征：一项描述性研究。
Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.
5
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.胸部计算机断层扫描在 2019 年冠状病毒病（COVID-19）中的表现：与感染持续时间的关系。
Radiology. 2020 Jun;295(3):200463. doi: 10.1148/radiol.2020200463. Epub 2020 Feb 20.
6
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
7
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).新冠肺炎（COVID-19）康复过程中胸部 CT 肺部变化的时间进程。
Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
10
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials.免疫治疗药物与化疗药物在实体瘤中的不良反应谱比较：一项随机临床试验的系统评价和荟萃分析。
Ann Oncol. 2020 Jan;31(1):50-60. doi: 10.1016/j.annonc.2019.10.008.